Entity
Description
Value proposition
Ancilia is harnessing the natural power of CRISPR to develop a new class of bacterial therapies and products for a range of applications.
Home | Ancilia Bio
CRISPR-mediated viral immunity. Designed by nature, harnessed by Ancilia
https://www.anciliabio.com/
Catalyst interactions
| Catalyst | Type | Tweets | Articles | |
|---|---|---|---|---|
 Deep Science Ventures Startup accelerator & VC, Venture Capital and Private Equity Principals | Deep Science Ventures Startup accelerator & VC, Venture Capital and Private Equity Principals | Other 2 Apr 2025 | | |
Social network dynamics
Last news Show all articles
Loading...